Which CEO founded the first major company to commercialize CRISPR gene-editing technology for therapeutic applications?

CRISPR gene-editing technology represents one of the most significant scientific breakthroughs in recent decades, revolutionizing how we approach genetic engineering, disease treatment, and biological research. This poll tests your knowledge about the commercialization of this groundbreaking scientific tool and the visionary leaders behind it.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• Jennifer Doudna, co-founder of Caribou Biosciences and later Mammoth Biosciences
• Rachel Haurwitz, founding CEO of Caribou Biosciences
• Feng Zhang, co-founder of Editas Medicine
• Katrine Bosley, founding CEO of Editas Medicine who led its IPO in 2016

Powered by AIPolls.Net — AI-powered real-time polling platform.